These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 21712169

  • 1. Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
    Rayan M, Tawfik M, Alabd A, Gamal A.
    Anadolu Kardiyol Derg; 2011 Aug; 11(5):402-6. PubMed ID: 21712169
    [Abstract] [Full Text] [Related]

  • 2. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Mar 15; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P.
    Circulation; 2001 Feb 27; 103(8):1083-8. PubMed ID: 11222470
    [Abstract] [Full Text] [Related]

  • 6. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 7. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 8. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M, Talajic M, Robertson M, Tardif JC, Ferrari R, Ford I, Steg PG, Fox K, BEAUTIFUL Investigators.
    Am J Cardiol; 2011 Mar 15; 107(6):805-11. PubMed ID: 21247517
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

  • 10. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.
    Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328
    [Abstract] [Full Text] [Related]

  • 11. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S, Slomka S, Zielinska-Wyderkiewicz E, Ciebiada M, Gorski P.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):179-88. PubMed ID: 22409211
    [Abstract] [Full Text] [Related]

  • 12. Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Malebranche R, Tabou Moyo C, Morisset PH, Raphael NA, Wilentz JR.
    Am Heart J; 2016 Aug 01; 178():151-60. PubMed ID: 27502863
    [Abstract] [Full Text] [Related]

  • 13. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Aug 01; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 14. Suppression of frequent premature ventricular contractions and improvement of left ventricular function in patients with presumed idiopathic dilated cardiomyopathy.
    Duffee DF, Shen WK, Smith HC.
    Mayo Clin Proc; 1998 May 01; 73(5):430-3. PubMed ID: 9581582
    [Abstract] [Full Text] [Related]

  • 15. Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine.
    Raja DC, Kapoor A, Sinha A, Kashyap S, Khanna R, Kumar S, Garg N, Tewari S, Goel P.
    Indian Heart J; 2018 May 01; 70(2):246-251. PubMed ID: 29716702
    [Abstract] [Full Text] [Related]

  • 16. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G.
    Am J Cardiol; 2012 Mar 01; 109(5):729-35. PubMed ID: 22176998
    [Abstract] [Full Text] [Related]

  • 17. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 01; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 18. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME, Berliner JI, Shah SJ, Taegtmeyer H, Gheorghiade M.
    Am J Ther; 2008 May 01; 15(3):206-13. PubMed ID: 18496257
    [Abstract] [Full Text] [Related]

  • 19. Heart rate variability in dilated cardiomyopathy.
    Biswas PK, Basu S, Mitra KK, Chowdhury SP, Chatterjee BP, Das Biswas A, Chatterjee SS, Maity AK.
    Indian Heart J; 2000 May 01; 52(2):187-91. PubMed ID: 10893896
    [Abstract] [Full Text] [Related]

  • 20. [How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
    Fukuda K, Handa S, Ogawa S, Nakamura Y, Kawamura Y.
    J Cardiol; 1990 May 01; 20(3):755-65. PubMed ID: 2151866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.